Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Arnould L, Viola F, Zarranz-Ventura J, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Among authors: barthelmes d. Ophthalmol Retina. 2022 Nov;6(11):1044-1053. doi: 10.1016/j.oret.2022.05.008. Epub 2022 May 16. Ophthalmol Retina. 2022. PMID: 35589075 Free article.
Differential optical densities of intraretinal spaces.
Barthelmes D, Sutter FK, Gillies MC. Barthelmes D, et al. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3529-34. doi: 10.1167/iovs.07-1320. Epub 2008 Apr 25. Invest Ophthalmol Vis Sci. 2008. PMID: 18441298 Free article.
Familial asymptomatic macular telangiectasia type 2.
Gillies MC, Zhu M, Chew E, Barthelmes D, Hughes E, Ali H, Holz FG, Scholl HP, Charbel Issa P. Gillies MC, et al. Among authors: barthelmes d. Ophthalmology. 2009 Dec;116(12):2422-9. doi: 10.1016/j.ophtha.2009.05.010. Epub 2009 Oct 7. Ophthalmology. 2009. PMID: 19815294 Free PMC article.
Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes.
Gillies MC, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Hunyor AP, Essex RW, Morlet N, Barthelmes D; Fight Retinal Blindness! Project Investigators. Gillies MC, et al. Among authors: barthelmes d. Invest Ophthalmol Vis Sci. 2013 Aug 27;54(8):5754-60. doi: 10.1167/iovs.13-11993. Invest Ophthalmol Vis Sci. 2013. PMID: 23821201 Free article.
Anti-retinal antibodies in patients with macular telangiectasia type 2.
Zhu L, Shen W, Zhu M, Coorey NJ, Nguyen AP, Barthelmes D, Gillies MC. Zhu L, et al. Among authors: barthelmes d. Invest Ophthalmol Vis Sci. 2013 Aug 21;54(8):5675-83. doi: 10.1167/iovs.13-12050. Invest Ophthalmol Vis Sci. 2013. PMID: 23882694 Free article.
209 results